News

Consumer support group Allergy and Anaphylaxis Australia has made the difficult decision to cancel this year’s plans for their annual awareness-raising Food Allergy Week, previously scheduled for 24-30 May 2020. Due to the COVID-19 crisis, they are instead focusing on…

With the world’s first peanut oral immunotherapy now approved by the U.S. Food and Drug Administration, there is ample evidence to support the efficacy and safety of this novel treatment for peanut allergy. A new piece of work has looked…

Coeliac disease can cause several long-term complications that have been previously shown to impact life expectancy. However, in light of improved rates of early diagnosis and wider availability of gluten-free foods to help manage the condition, a recent study conducted…

A Victorian research collaboration between Barwon Health, Deakin University and Murdoch Children’s Research Institute has linked the presence of the Prevotella copri bacteria in a mother’s gut during pregnancy with allergic disease protection in her baby. Consistent with the ‘hygiene…

Some evidence suggests consumption of specific enzymes that degrade the proline and glutamine amino acids that make up gluten proteins may help those with coeliac disease. New research carried out at New Zealand’s Riddet Institute has trialled the use of…

A survey by Allergy & Anaphylaxis Australia (A&AA) has previously revealed that 70 per cent of people living with a food allergy or intolerance felt uncomfortable when dining out. A new Melbourne-based technology business, TLRT Foods (pronounced tolerate), believes they have…